US actions have serious impact on global health, WHO chief says
The United States' pause on foreign aid contributions is having a serious impact on global health, hitting programmes ...
UN News Centre1d
US funding cuts threaten global health response, WHO chief warns
The World Health Organization (WHO) has expressed deep concern over the impact of US funding cuts on critical global health ...
U.S. pause on foreign aid is having a serious impact on global health, WHO chief says
World Health Organization Director-General Tedros Adhanom Ghebreyesus urged the country to consider resuming aid funding ...
Hosted on MSN23h
US Government actions having a serious impact on global health, WHO chief says
Speaking publicly for the first time about the USAID freeze, Dr Tedros has asked the US to reconsider its position.
Fifty countries affected by USAID freeze, says WHO
Programmes to tackle HIV, polio, mpox and bird flu have been affected by the freeze on tens of billions of dollars of ...
Devex2d
WHO chief eyes idea of a $50B endowment fund to plug resource gaps
While WHO has made some progress in broadening its donor base, it still requires more flexible resources, especially with the ...
Accent on investment in medical research and development
Dr. Soumya Swaminathan emphasizes government and private sector investment in research and development for advancing ...
Tempo5h
BPOM Chief: No Service Changes Despite 41% Budget Cut
TEMPO.CO, Jakarta - The Head of the National Agency of Drug and Food Control (BPOM), Taruna Ikrar, has assured that there ...
AFP on MSN1d
Vaccine critic RFK Jr. confirmed as US health secretary
The Republican-controlled US Senate confirmed Robert F. Kennedy Jr. as health secretary Thursday, elevating his anti-vaccine ...
Funding Freeze Decimates Women’s Health Care, U.N. and Others Say
Only three weeks into the Trump administration’s suspension of money for foreign aid, those who work in women’s health say ...
BMJ2d
Can WHO’s new trials guidance challenge a lack of inclusivity in research?
The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...